256 related articles for article (PubMed ID: 25004955)
21. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
22. Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer.
Jin J; Xiang W; Wu S; Wang M; Xiao M; Deng A
Biochem Biophys Res Commun; 2019 Mar; 510(4):580-586. PubMed ID: 30739792
[TBL] [Abstract][Full Text] [Related]
23. Targeting the oncogene eIF4E in cancer: From the bench to clinical trials.
Borden KL
Clin Invest Med; 2011 Dec; 34(6):E315. PubMed ID: 22129918
[TBL] [Abstract][Full Text] [Related]
24. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
25. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
[TBL] [Abstract][Full Text] [Related]
27. The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression.
Sadeh-Mestechkin D; Epstein Shochet G; Pomeranz M; Fishman A; Drucker L; Biron-Shental T; Lishner M; Tartakover Matalon S
Mol Hum Reprod; 2014 May; 20(5):422-32. PubMed ID: 24431103
[TBL] [Abstract][Full Text] [Related]
28. The oncogene eIF4E: using biochemical insights to target cancer.
Carroll M; Borden KL
J Interferon Cytokine Res; 2013 May; 33(5):227-38. PubMed ID: 23472659
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
Topisirovic I; Ruiz-Gutierrez M; Borden KL
Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
[TBL] [Abstract][Full Text] [Related]
30. Role of the highly structured 5'-end region of MDR1 mRNA in P-glycoprotein expression.
Randle RA; Raguz S; Higgins CF; Yagüe E
Biochem J; 2007 Sep; 406(3):445-55. PubMed ID: 17573715
[TBL] [Abstract][Full Text] [Related]
31. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
33. The MAP kinase-interacting kinases (MNKs) as targets in oncology.
Xie J; Merrett JE; Jensen KB; Proud CG
Expert Opin Ther Targets; 2019 Mar; 23(3):187-199. PubMed ID: 30650992
[TBL] [Abstract][Full Text] [Related]
34. Taking aim at translation for tumor therapy.
Barnhart BC; Simon MC
J Clin Invest; 2007 Sep; 117(9):2385-8. PubMed ID: 17786234
[TBL] [Abstract][Full Text] [Related]
35. Anti-oncogenic potential of the eIF4E-binding proteins.
Martineau Y; Azar R; Bousquet C; Pyronnet S
Oncogene; 2013 Feb; 32(6):671-7. PubMed ID: 22508483
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
Cao J; Sun X; Zhang X; Chen D
Clin Transl Oncol; 2018 Jun; 20(6):761-767. PubMed ID: 29086249
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.
Li J; Huang Y; Gao Y; Wu H; Dong W; Liu L
Biochem Biophys Res Commun; 2016 Apr; 472(2):299-305. PubMed ID: 26944016
[TBL] [Abstract][Full Text] [Related]
38. The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.
Kjellerup RB; Iversen L; Kragballe K; Johansen C
Br J Dermatol; 2009 Nov; 161(5):1059-66. PubMed ID: 19663871
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.
Ko SY; Guo H; Barengo N; Naora H
Clin Cancer Res; 2009 Jul; 15(13):4336-47. PubMed ID: 19458052
[TBL] [Abstract][Full Text] [Related]
40. Eukaryotic translation initiation is controlled by cooperativity effects within ternary complexes of 4E-BP1, eIF4E, and the mRNA 5' cap.
Modrak-Wojcik A; Gorka M; Niedzwiecka K; Zdanowski K; Zuberek J; Niedzwiecka A; Stolarski R
FEBS Lett; 2013 Dec; 587(24):3928-34. PubMed ID: 24211447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
